Sitemap > Clinical Trials > Psychiatric, Addictive & Sleep Disorders
Displaying 1 - 50 of 327 results
- An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression
- An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
- Staccatoâ„¢ Alprazolam for Inhalation in Panic Attack
- Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia.
- Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
- An 8 Week Study to Evaluate Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
- Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
- Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
- FAST - A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
- Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia
- GSK1014802 Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
- Study Evaluating RGH-188 in the Treatment of Patients With Acute Mania
- AZD6765 for Treatment Resistant Depression
- A Study to Assess Facilitation of the Discontinuation of Zolpidem by Ramelteon Administration in Subjects With Chronic Insomnia
- Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
- Varenicline Adjunctive Treatment in Schizophrenia
- Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects
- MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia
- A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With ORG 50081.
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Antidepressant Medication and Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
- Olanzapine Treatment of Patients With Bipolar I Disorder
- Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-Episode Psychosis-a Pilot Study
- A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
- Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
- A Study of the Use of Combination of Anti-Cholinergic and Minor Tranquilliser in the Treatment of Non-Cardiac Chest Pain - a Double Blind Placebo Controlled Study
- Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
- The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
- Quetiapine Efficacy in Bipolar Depression Study
- Seroquel Long-Term NIS for Schizophrenia Patients
- A Safety and Efficacy Study of ABT-089 in Children With Attention Deficit-Hyperactivity Disorder (ADHD)
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
- Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
- An Eight-Week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
- A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
- Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
- Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
- Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
- Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
- Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia
- A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence
- High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable
- A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers
- Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
- A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder